• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性心肌梗死溶栓治疗后出现不明原因的严重出血并伴有晕厥。

Unrecognized major bleeding following thrombolysis for acute myocardial infarction presenting with syncope.

作者信息

Cohen N, Zaidenstein R, Blatt A, Sarafian D A, Litinsky I, Modai D

机构信息

Department of Internal Medicine A, Assaf Harofeh Medical Center, Zerifin, Israel.

出版信息

Clin Cardiol. 1998 Aug;21(8):599-601. doi: 10.1002/clc.4960210813.

DOI:10.1002/clc.4960210813
PMID:9702389
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6655327/
Abstract

Complete atrioventricular block and syncope sometimes are the presenting signs of acute myocardial infarction. In a presyncopal attempt to assume sitting position, the patient may fall and suffer consequent trauma. Once in hospital, this sequence of events may be overlooked by both the patient and admitting physicians. Moreover, physical examination initially may not be revealing. We report on two such patients who developed massive subcutaneous bleeding following thrombolytic and heparin treatment. We conclude that these patients constitute a specific group with a relatively high risk of trauma and bleeding at the gluteal region following thrombolytic therapy. Special attention must be given to these patients.

摘要

完全性房室传导阻滞和晕厥有时是急性心肌梗死的首发症状。在晕厥前试图坐起时,患者可能会摔倒并因此受伤。一旦住院,患者和收治医生可能都会忽略这一系列事件。此外,最初的体格检查可能并无异常发现。我们报告了两名此类患者,他们在接受溶栓和肝素治疗后出现了大量皮下出血。我们得出结论,这些患者构成了一个特殊群体,在溶栓治疗后臀部区域有相对较高的创伤和出血风险。必须对这些患者给予特别关注。

相似文献

1
Unrecognized major bleeding following thrombolysis for acute myocardial infarction presenting with syncope.急性心肌梗死溶栓治疗后出现不明原因的严重出血并伴有晕厥。
Clin Cardiol. 1998 Aug;21(8):599-601. doi: 10.1002/clc.4960210813.
2
Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
J Am Coll Cardiol. 1993 Sep;22(3):707-13. doi: 10.1016/0735-1097(93)90180-9.
3
"Rescue" thrombolysis with intracoronary tissue plasminogen activator for failed intravenous thrombolysis with streptokinase for acute myocardial infarction.
Am J Cardiol. 1995 Jan 15;75(2):172-4. doi: 10.1016/s0002-9149(00)80070-3.
4
Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.接受溶栓治疗的急性心肌梗死女性和男性患者的特征及预后比较。GUSTO-I研究组。
JAMA. 1996 Mar 13;275(10):777-82.
5
Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.糖尿病对急性心肌梗死溶栓时代临床结局的影响。GUSTO-I研究人员。链激酶和组织型纤溶酶原激活剂在闭塞冠状动脉中的全球应用。
J Am Coll Cardiol. 1997 Jul;30(1):171-9. doi: 10.1016/s0735-1097(97)00118-6.
6
Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.糖尿病视网膜病变不应成为急性心肌梗死溶栓治疗的禁忌证:对GUSTO-I试验中眼内出血发生率及部位的回顾。全球应用链激酶和组织型纤溶酶原激活剂治疗冠状动脉闭塞。
J Am Coll Cardiol. 1997 Dec;30(7):1606-10. doi: 10.1016/s0735-1097(97)00394-x.
7
Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.溶栓相关颅内出血:对来自GUSTO-1试验的244例病例的影像学分析及临床相关性。链激酶和组织型纤溶酶原激活剂在冠状动脉闭塞中的全球应用。
Stroke. 1998 Mar;29(3):563-9. doi: 10.1161/01.str.29.3.563.
8
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.一项比较四种急性心肌梗死溶栓策略的国际随机试验。
N Engl J Med. 1993 Sep 2;329(10):673-82. doi: 10.1056/NEJM199309023291001.
9
New developments in thrombolytic therapy.溶栓治疗的新进展。
Adv Exp Med Biol. 1990;281:333-54.
10
The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.组织型纤溶酶原激活剂、链激酶或两者联用对急性心肌梗死后冠状动脉通畅、心室功能及生存率的影响。
N Engl J Med. 1993 Nov 25;329(22):1615-22. doi: 10.1056/NEJM199311253292204.

本文引用的文献

1
Early management of myocardial infarction. Confirm diagnosis before giving thrombolytic treatment.心肌梗死的早期处理。在给予溶栓治疗前确诊。
BMJ. 1994 Apr 30;308(6937):1159-60. doi: 10.1136/bmj.308.6937.1159d.
2
Thrombolytic therapy for acute myocardial infarction. Are inclusion criteria too stringent?急性心肌梗死的溶栓治疗。纳入标准是否过于严格?
Postgrad Med. 1994 Mar;95(4):77-82.
3
Thrombolysis after acute myocardial infarction. Who should be added to inclusion criteria?急性心肌梗死后的溶栓治疗。纳入标准应增加哪些人群?
Postgrad Med. 1994 Dec;96(8):30-4, 37-40.
4
Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.静脉注射组织型纤溶酶原激活剂与急性心肌梗死的梗死面积、左心室功能及生存率
BMJ. 1988 Nov 26;297(6660):1374-9. doi: 10.1136/bmj.297.6660.1374.
5
Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.心肌梗死溶栓治疗研究中急性心肌梗死后及溶栓治疗后的脑出血、脑梗死和硬膜下血肿。心肌梗死溶栓治疗,第二阶段,试点及临床试验。
Circulation. 1991 Feb;83(2):448-59. doi: 10.1161/01.cir.83.2.448.
6
Clinical risks of thrombolytic therapy.
Am J Cardiol. 1992 Jan 3;69(2):12A-20A. doi: 10.1016/0002-9149(92)91168-4.